Why NAD+ Is Not Recommended During Pregnancy

NAD+ has not been studied in pregnant women or during lactation. The peptide's biological effects on cellular pathways could theoretically influence fetal development, though no specific harm has been documented .

Without reproductive safety data, the standard medical approach is avoidance. This applies to all phases: trying to conceive, pregnancy, and breastfeeding.

When to Stop Before Conception

Most physicians recommend discontinuing NAD+ at least 4 to 6 weeks before attempting to conceive. This conservative washout period ensures the peptide has cleared your system before pregnancy begins.

If you discover you are pregnant while using NAD+, stop immediately and inform your obstetrician about your recent use.

Resuming After Pregnancy

You can discuss restarting NAD+ with your physician after you have completed pregnancy and breastfeeding. Plan to:

• Wait until fully done breastfeeding
• Get a postpartum health evaluation
• Restart at your original starting dose
• Monitor your response carefully, as postpartum physiology may differ from your pre-pregnancy baseline

Frequently Asked Questions

Is NAD+ right for me?

NAD+ may be appropriate depending on your health goals, medical history, and current medications. Consult with a physician who specializes in peptide therapy to determine whether it fits your individual situation.

How quickly will I see results from NAD+?

Initial effects may be noticed within 1 to 2 weeks, with more significant changes typically emerging over 4 to 8 weeks. Individual response varies based on dosage, health status, and lifestyle factors.

Is NAD+ FDA-approved?

NAD+ is not FDA-approved for any medical condition. It is available through physician-supervised compounding pharmacies and research channels. All use should be under medical oversight.

Form Blends offers physician-supervised peptide therapy. Start your consultation to discuss whether NAD+ is right for your goals.